Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does treatment with eicosapentaenoic acid prevent major coronary events in patients with hypercholesterolemia?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 532–533 (2007)Cite this article

Access through your institution
Buy or subscribe

boxed-textYokoyama M et al. for the Japan EPA lipid intervention study Investigators (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090–1098

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Iso H et al. for the JPHC Study Group (2006) Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113: 195–202

    Article  CAS  Google Scholar 

  2. Harris WS et al. (2006) Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol 98: 19i–26i

    Article  CAS  Google Scholar 

  3. Harris WS (2006) The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 8: 453–459

    Article  CAS  Google Scholar 

  4. Thies F et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361: 477–485

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Nutrition and Metabolic Disease Research Institute, Sanford School of Medicine, University of South Dakota, 1400 W 22nd Street, Sioux Falls, SD 57105, USA bill.harris@usd.edu

Authors and Affiliations

  1. WS Harris is a Research Professor of Medicine, and Director of the Nutrition and Metabolic Disease Research Center, at the Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.,

    William S Harris

Authors
  1. William S Harris
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

WS Harris has acted as a consultant and has received Speakers' Bureau honoraria and research support from Monsanto and Reliant Pharmaceuticals

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, W. Does treatment with eicosapentaenoic acid prevent major coronary events in patients with hypercholesterolemia?. Nat Rev Cardiol 4, 532–533 (2007). https://doi.org/10.1038/ncpcardio0967

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpcardio0967

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing